Cited by 8Lipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismAntiplatelet Therapy and Cardiovascular Diseases

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Reassessing Benefits and Risks of Statins

Rita F. Redberg, Mitchell H. Katz·2012·New England Journal of Medicine

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmc1207079

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Wright JM, 2010, Ther Lett, 77, 1
  2. Taylor F, 2011, Cochrane Database Syst Rev, 1, CD004816
  3. 10.1056/NEJMp1203020 · DOI

Cited by

Sorted by citations

Metadata

Authors
Redberg, R. F., & Katz, M. H.
Venue
New England Journal of Medicine
Published
2012-08-23
Volume
367
Issue
8
Pages
776-776
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W8643303
Cited by
8
References
5
Citations by year
2019: 1 · 2016: 4 · 2015: 2 · 2013: 1
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
statins, cardiovascular risk reduction, drug benefits and risks, lipid-lowering therapy, cardiovascular disease prevention
MeSH terms
Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review